✦ LIBER ✦

Mutation of the class I β-tubulin gene does not predict response to paclitaxel for breast cancer

✍ Scribed by Kazuma Maeno; Ken-ichi Ito; Yoshihisa Hama; Kiyoshi Shingu; Morihiko Kimura; Muneaki Sano; Hiroshi Nakagomi; Shin-ichi Tsuchiya; Minoru Fujimori

Book ID: 117467845
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 198 KB
Volume: 198
Category: Article
ISSN: 0304-3835
DOI: 10.1016/s0304-3835(03)00279-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutational analysis of the class I β-tub

Mutational analysis of the class I β-tubulin gene in human breast cancer

✍ Seiichi Hasegawa; Yasuo Miyoshi; Chiyomi Egawa; Makoto Ishitobi; Yasuhiro Tamaki 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB

Non-small cell lung cancers have a high incidence of somatic mutations of the beta-tubulin (class I) gene, suggesting involvement in the acquisition of resistance to taxanes, which exert their effects through binding to beta-tubulin. Since taxanes are often used in the treatment of breast cancer, we

Germline BRCA mutation does not prevent

Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer

✍ David J. Gallagher; Angel M. Cronin; Matthew I. Milowsky; Michael J. Morris; Jas 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB